利钠肽受体A抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 利钠肽受体A抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Guanylyl cyclases, catalyzing the production of cGMP from GTP, are classified as soluble and membrane forms (Garbers and Lowe, 1994 [PubMed 7982997]). The membrane guanylyl cyclases, often termed guanylyl cyclases A through F, form a family of cell-surface receptors with a similar topographic structure: an extracellular ligand-binding domain, a single membrane-spanning domain, and an intracellular region that contains a protein kinase-like domain and a cyclase catalytic domain. GC-A and GC-B function as receptors利钠肽受体A抗体 for natriuretic peptides; they are also referred to as atrial natriuretic peptide receptor A (NPR1) and type B (NPR2; MIM 108961). Also see NPR3 (MIM 108962), which encodes a protein with only the ligand-binding transmembrane and 37-amino acid cytoplasmic domains. NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP (MIM 108780) and BNP (MIM 600295), respectively).[supplied by OMIM, May 2009]

利钠肽受体A抗体Also known as:

NPRA; ANP A; ANP-A; ANPa; ANPR-A; ANPRA; ANPRA_HUMAN; Atrial natriuretic peptide A type receptor; Atrial natriuretic peptide receptor 1; Atrial natriuretic peptide receptor A; Atrial natriuretic peptide receptor type A; Atrionatriuretic peptide receptor A; GC A; GC-A; Guanylate cyclase A; Guanylate cyclase; GUC2A; GUCY2A; Natriuretic peptide A type receptor; Natriuretic peptide receptor A/guanylate cyclase A; NPR 1; NPR A; NPR-A; NPR1; NPRA.

Specificity:

●

Rabbit Polyclonal IgG,利钠肽受体A抗体 affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, .

●

Immunogen: KLH conjugated synthetic peptide derived from human Natriuretic Peptide Receptor A.

●

Predicted Molecular Weight: 113kDa.

利钠肽受体A抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

IHC-P=1:100-500  IHC-F=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl041Hu01围脂滴蛋白3(PLIN3)多克隆抗体Polyclonal Antibody to Perilipin 3 (PLIN3)

kl045Ra01大麻素受体2(CNR2)多克隆抗体Polyclonal Antibody to Cannabinoid Receptor 2, Macrophage (CNR2)

kl047Hu01原钙黏素γA2(PCDHγA2)多克隆抗体Polyclonal Antibody to Protocadherin Gamma A2 (PCDHgA2)

kl072Hu01原钙黏素β16(PCDHβ16)多克隆抗体Polyclonal Antibody to Protocadherin Beta 16 (PCDHb16)

kl095Hu01原钙黏素15(PCDH15)多克隆抗体Polyclonal Antibody to Protocadherin 15 (PCDH15)

kl095Mu01原钙黏素15(PCDH15)多克隆抗体Polyclonal Antibody to Protocadherin 15 (PCDH15)

kl107Hu01肝配蛋白A1(EFNA1)多克隆抗体Polyclonal Antibody to Ephrin A1 (EFNA1)

kl109Hu01肝配蛋白A3(EFNA3)多克隆抗体Polyclonal Antibody to Ephrin A3 (EFNA3)

kl110Hu01肝配蛋白A4(EFNA4)多克隆抗体Polyclonal Antibody to Ephrin A4 (EFNA4)

kl111Hu01肝配蛋白A5(EFNA5)多克隆抗体Polyclonal Antibody to Ephrin A5 (EFNA5)

kl112Hu01肝配蛋白B2(EFNB2)多克隆抗体Polyclonal Antibody to Ephrin B2 (EFNB2)

kl112Mu01肝配蛋白B2(EFNB2)多克隆抗体Polyclonal Antibody to Ephrin B2 (EFNB2)

kl118Mu01肝配蛋白B受体3(EPHB3)多克隆抗体Polyclonal Antibody to Ephrin Type B Receptor 3 (EPHB3)

kl118Ra01肝配蛋白B受体3(EPHB3)多克隆抗体Polyclonal Antibody to Ephrin Type B Receptor 3 (EPHB3)

kl122Hu01肝配蛋白A受体10(EPHA10)多克隆抗体Polyclonal Antibody to Ephrin Type A Receptor 10 (EPHA10)

kl131Hu01乳酸脱氢酶C(LDHC)多克隆抗体Polyclonal Antibody to Lactate Dehydrogenase C (LDHC)

kl134Hu01防御素α6(DEFα6)多克隆抗体Polyclonal Antibody to Defensin Alpha 6, kleth Cell Specific (DEFa6)

kl135Hu01防御素α3(DEFα3)多克隆抗体Polyclonal Antibody to Defensin Alpha 3, Neutrophil Specific (DEFa3)

kl140Hu01γ-谷氨酰基转氨酶5(γGT5)多克隆抗体Polyclonal Antibody to Gamma-Glutamyltransferase 5 (gGT5)

kl144Hu01脂质运载蛋白9(LCN9)多克隆抗体Polyclonal Antibody to Lipocalin 9 (LCN9)

kl149Mu01母系蛋白2(MATN2)多克隆抗体Polyclonal Antibody to Matrilin 2 (MATN2)